Cardiac involvement in systemic lupus erythematosus
- PMID: 10089998
- DOI: 10.4065/74.3.275
Cardiac involvement in systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE), a connective tissue disease characterized by the production of autoantibodies, can affect all organ systems. Cardiac involvement in patients with SLE has been described since the early 20th century. The manifestations are numerous and can involve all components of the heart, including the pericardium, conduction system, myocardium, valves, and coronary arteries. In recent years, echocardiography has yielded additional information about the heart in patients who have SLE with and without clinical cardiac involvement. Moreover, antiphospholipid antibodies have been linked to several cardiac manifestations in patients with SLE, including valvular abnormalities and possibly coronary artery disease. This updated, comprehensive review summarizes the new literature on SLE and the heart.
Comment in
-
Pulmonary hypertension in systemic lupus erythematosus.Mayo Clin Proc. 1999 Aug;74(8):845. doi: 10.4065/74.8.845. Mayo Clin Proc. 1999. PMID: 10473368 No abstract available.
-
Hypertrophic cardiomyopathy in systemic lupus erythematosus.Mayo Clin Proc. 2001 Jan;76(1):111. doi: 10.4065/76.1.111. Mayo Clin Proc. 2001. PMID: 11155404 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
